chr9-133475074-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_017585.4(SLC2A6):c.814G>A(p.Val272Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000407 in 1,597,584 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_017585.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC2A6 | NM_017585.4 | c.814G>A | p.Val272Met | missense_variant | 6/10 | ENST00000371899.9 | NP_060055.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC2A6 | ENST00000371899.9 | c.814G>A | p.Val272Met | missense_variant | 6/10 | 1 | NM_017585.4 | ENSP00000360966.4 | ||
SLC2A6 | ENST00000371897.8 | c.814G>A | p.Val272Met | missense_variant | 6/9 | 2 | ENSP00000360964.4 | |||
SLC2A6 | ENST00000485978.1 | n.1402G>A | non_coding_transcript_exon_variant | 5/8 | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000854 AC: 13AN: 152246Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.0000491 AC: 11AN: 224088Hom.: 0 AF XY: 0.0000408 AC XY: 5AN XY: 122614
GnomAD4 exome AF: 0.0000360 AC: 52AN: 1445338Hom.: 0 Cov.: 30 AF XY: 0.0000376 AC XY: 27AN XY: 717926
GnomAD4 genome AF: 0.0000854 AC: 13AN: 152246Hom.: 0 Cov.: 34 AF XY: 0.0000941 AC XY: 7AN XY: 74382
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 07, 2024 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at